Diabetes Mellitus, Type 1
10 competing products in clinical development for Diabetes Mellitus, Type 1.
Pipeline by Phase
Phase 14
Phase 36
All Products (10)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Nasal Glucagon + Intramuscular Glucagon | Eli Lilly | Phase 3 | Completed | 77 |
| LY2963016 + Lantus + Insulin Lispro | Eli Lilly | Phase 3 | Completed | 77 |
| Human Insulin Inhalation Powder + Injectable insulin + Insulin Glargine | Eli Lilly | Phase 3 | Completed | 77 |
| Human Insulin Inhalation Powder + Injectable Insulin + Insulin Glargine | Eli Lilly | Phase 3 | Completed | 77 |
| Empagliflozin + Empagliflozin + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
| Lantus Solostar, 100 Units/mL Subcutaneous Solution + Insulin RinGlar, 100 Units/mL Subcutaneous Solution | GEROPHARM | Phase 3 | Completed | 69 |
| LY2963016 + Lantus | Eli Lilly | Phase 1 | Completed | 33 |
| LY4057996 SC + LY4057996 IV + Placebo SC + Placebo IV + Degludec SC + Lispro SC + Degludec IV + Pre-study basal insulin SC | Eli Lilly | Phase 1 | Recruiting | 33 |
| Insulin Peglispro + Insulin Lispro + Insulin Glargine | Eli Lilly | Phase 1 | Completed | 33 |
| LY900014 + Insulin Lispro | Eli Lilly | Phase 1 | Completed | 33 |